Skip to content

Clinical observation of the treatment of conjunctival lymphangiectasia combined with puncture aspiration and cystic wall aspiration

Clinical observation of the treatment of conjunctival lymphangiectasia combined with puncture aspiration and cystic wall aspiration

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098705
Enrollment
Unknown
Registered
2025-03-12
Start date
2025-02-02
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conjunctival lymphangiectasia is a blockage of the conjunctival lymphatic vessels that leads to poor drainage and subsequent lymphangiectasia. The exact cause is unknown, but it may be associated with inflammation, infection, trauma, and systemic disease. The clinical manifestations were localized cyst or beaded swelling of conjunctiva. The main symptoms included foreign body sensation, swelling,

Interventions

A group:Puncture aspiration combined with capsular wall aspiration
B group:Puncture drainage
C group:Surgical excision

Sponsors

Xi'an Jiaotong University Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The clinical diagnosis was conjunctival lymphangiectasia, which was classified as cystoid local type with good activity. 2. Not responding to medication. 3. Generally in good physical condition, no major cardiopulmonary and systemic diseases. 4. No previous history of ocular surface surgery.

Exclusion criteria

Exclusion criteria: 1. The clinical diagnosis was conjunctival lymphangiectasis, and the types were diffuse type or pearl string type. 2. The symptoms were alleviated and cysts decreased after drug treatment. 3. Patients with severe organ dysfunction in the whole body who cannot tolerate operation or surgery; 4. Previous history of ocular surface, ocular trauma or intraocular surgery.

Design outcomes

Primary

MeasureTime frame
Therapeutic effectiveness;Complete extraction rate;Time of disappearance of foreign body sensation;Economic expenditure;Recurrence rate;

Countries

China

Contacts

Public ContactLing Bai

Xi'an Jiaotong University Second Affiliated Hospital

larkling@163.com+86 29 87678326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026